Glenmark starts phase IIb human trials of molecule – mydigitalfc.com


Moneycontrol.com

Glenmark starts phase IIb human trials of molecule
mydigitalfc.com
Glenmark is positioning Revlimast as a treatment for chronic inflammatory disorders such as asthma and rheumatoid arthritis. Rheumatoid arthritis and asthma drugs are estimated to have a market in excess of $20 billion each.
Glenmark starts Phase-IIb human trials of Revamilast moleculeEconomic Times
Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule PR Newswire (press release)

all 28 news articles »

View full post on asthma – Google News

Glenmark starts Phase-IIb human trials of Revamilast molecule – Economic Times

Glenmark starts Phase-IIb human trials of Revamilast molecule
Economic Times
NEW DELHI: Glenmark Pharmaceuticals on Wednesday said it has started Phase-IIb human trials of its 'Revamilast' molecule, which is being developed for treatment of inflammatory disorders like asthma and rheumatoid arthritis. The Phase-IIb studies of
Glenmark initiates Phase IIb human trials globally for its novel molecule India Infoline.com

all 7 news articles »

View full post on asthma – Google News

Biological Trials linked to Viral Infection in Asthma Patients – TopNews United States


MSN News UK

Biological Trials linked to Viral Infection in Asthma Patients
TopNews United States
A recent study by researchers at Children's Hospital Boston has found that biological trials can help in understanding the reason behind asthma attacks in children caused due to influenza. Hitherto it was unknown but now scientists have found a link
Why influenza induces asthma attacks?Times of India
Why Flu Triggers Asthma Attacks in ChildreneMaxHealth
Why influenza induces asthma attacks?TruthDive
ABC Online –French Tribune –News Tonight
all 50 news articles »

View full post on asthma – Google News

Clinical trials start for ABI’s breath asthma check rapid assay – Stock Market Wire

Clinical trials start for ABI's breath asthma check rapid assay
Stock Market Wire
StockMarketWire.com – Clinical trials for Akers Biosciences' breath asthma check rapid assay have begun in Clearwater, Florida. The trials have been designed to provide the clinical information to be included in a submission for regulatory approvals
18 APRIL 2011 Akers Biosciences* AKR (FTSE AIM All Share) 4p BUY (TP-10p)AngelNews (press release) (subscription)

all 3 news articles »

View full post on asthma – Google News

FDA Requests Clinical Trials to Test Asthma Drugs Symbicort, Advair – DrugWatch.com

FDA Requests Clinical Trials to Test Asthma Drugs Symbicort, Advair
DrugWatch.com
On April 15, the Food and Drug Administration (FDA) announced that the drug makers of the popular asthma medications Symbicort, Advair Diskus, Dulera and Foradil will be required to conduct clinical trials to test the medications.
FDA orders safety studies for some asthma drugsReuters
FDA Drug Safety Communication: FDA requires post-market safety trials for Long Bioscience Technology

all 12 news articles »

View full post on asthma – Google News

Targacept to begin Phase 2 trials of drug that could treat asthma, diabetes – Winston-Salem Journal

Targacept to begin Phase 2 trials of drug that could treat asthma, diabetes
Winston-Salem Journal
Type 2 diabetes affects 198 million worldwide, and asthma affects about 65 million in just the world's seven major pharmaceutical markets — France, Germany
Targacept starts new trial for diabetes drugBizjournals.com
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 17 news articles »

View full post on asthma – Google News

Targacept to begin phase 2 trials for its anti-inflammatory drug compound – Winston-Salem Journal

Targacept to begin phase 2 trials for its anti-inflammatory drug compound
Winston-Salem Journal
said that the studies involve its drug compound TC-6987 for disorders related to inflammation – in this instance asthma and Type 2 diabetes.
Targacept starts new trial for diabetes drugBizjournals.com
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 13 news articles »

View full post on asthma – Google News